DSGN
Price
$3.77
Change
-$0.02 (-0.53%)
Updated
Jun 20, 11:30 AM (EDT)
Capitalization
215.15M
52 days until earnings call
SLDB
Price
$4.74
Change
+$0.09 (+1.94%)
Updated
Jun 20, 12:43 PM (EDT)
Capitalization
360.45M
Interact to see
Advertisement

DSGN vs SLDB

Header iconDSGN vs SLDB Comparison
Open Charts DSGN vs SLDBBanner chart's image
Design Therapeutics
Price$3.77
Change-$0.02 (-0.53%)
Volume$100
Capitalization215.15M
Solid Biosciences
Price$4.74
Change+$0.09 (+1.94%)
Volume$100
Capitalization360.45M
DSGN vs SLDB Comparison Chart in %
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. SLDB commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and SLDB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (DSGN: $3.79 vs. SLDB: $4.65)
Brand notoriety: DSGN and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 51% vs. SLDB: 63%
Market capitalization -- DSGN: $215.15M vs. SLDB: $360.45M
DSGN [@Biotechnology] is valued at $215.15M. SLDB’s [@Biotechnology] market capitalization is $360.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 6 TA indicator(s) are bullish while SLDB’s TA Score has 6 bullish TA indicator(s).

  • DSGN’s TA Score: 6 bullish, 2 bearish.
  • SLDB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than SLDB.

Price Growth

DSGN (@Biotechnology) experienced а -2.82% price change this week, while SLDB (@Biotechnology) price change was +0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

DSGN is expected to report earnings on Aug 11, 2025.

SLDB is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($360M) has a higher market cap than DSGN($215M). SLDB YTD gains are higher at: 16.250 vs. DSGN (-38.574). DSGN has higher annual earnings (EBITDA): -67.79M vs. SLDB (-136.83M). SLDB has more cash in the bank: 307M vs. DSGN (230M). DSGN has less debt than SLDB: DSGN (2.14M) vs SLDB (23.6M). DSGN (0) and SLDB (0) have equivalent revenues.
DSGNSLDBDSGN / SLDB
Capitalization215M360M60%
EBITDA-67.79M-136.83M50%
Gain YTD-38.57416.250-237%
P/E RatioN/AN/A-
Revenue00-
Total Cash230M307M75%
Total Debt2.14M23.6M9%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNSLDB
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 23 days ago
88%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFJAX32.780.14
+0.43%
Calvert US Large Cap Value Rspnb Idx A
RSCRX23.960.06
+0.25%
Russell Inv US Small Cap Equity R6
PGSLX11.460.01
+0.09%
Principal Global Sus Lstd Inf Inst
FOSKX72.130.05
+0.07%
Fidelity Overseas K
PROVX18.88-0.13
-0.68%
Provident Trust Strategy

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+2.99%
VRDN - DSGN
48%
Loosely correlated
+1.11%
KRYS - DSGN
47%
Loosely correlated
+1.59%
IDYA - DSGN
46%
Loosely correlated
-0.27%
AURA - DSGN
46%
Loosely correlated
-1.29%
SLDB - DSGN
44%
Loosely correlated
+0.87%
More